艾德生物(300685) - 2024 Q3 - 季度财报

Financial Performance - Revenue for Q3 2024 reached 304.95 million yuan, a 22.53% increase year-over-year[3] - Net profit attributable to shareholders in Q3 2024 was 83.41 million yuan, up 77.58% year-over-year[3] - Basic earnings per share for Q3 2024 were 0.21 yuan, a 75% increase year-over-year[3] - Weighted average return on equity for Q3 2024 was 4.92%, up 2.08 percentage points year-over-year[3] - Total operating revenue increased to 847,967,831.38 yuan, up 19.8% compared to the previous year's 707,591,539.73 yuan[15] - Net profit attributable to the parent company's owners increased to 1,174,863,865.61 yuan, up 16.6% from 1,007,161,728.46 yuan[14] - Net profit attributable to parent company shareholders increased to RMB 227.27 million, up 30.8% YoY from RMB 173.73 million[16] - Revenue from sales of goods and services reached RMB 810.77 million, up 14.1% YoY from RMB 710.55 million[18] - Basic earnings per share increased to RMB 0.57, up 29.5% YoY from RMB 0.44[16] - Total comprehensive income increased to RMB 227.33 million, up 31.1% YoY from RMB 173.43 million[16] Cash Flow and Investments - Operating cash flow for the first three quarters of 2024 was 240.28 million yuan, an 11.63% increase year-over-year[3] - Investment cash flow for the first three quarters of 2024 improved by 84.88% year-over-year, primarily due to reduced cash outflows for financial investments[6] - The company's net cash flow from financing activities in the first three quarters of 2024 decreased by 108.79% year-over-year, mainly due to increased share repurchases[6] - Operating cash flow increased to RMB 240.28 million, up 11.6% YoY from RMB 215.25 million[18] - Investment cash outflow decreased to RMB 440.12 million, down 33.0% YoY from RMB 657.38 million[18] - Cash and cash equivalents at the end of the period increased to RMB 252.96 million, up 29.5% YoY from RMB 195.34 million[19] - Cash paid for employee compensation increased to RMB 237.96 million, up 11.6% YoY from RMB 213.15 million[18] - Cash paid for taxes increased to RMB 68.51 million, up 67.7% YoY from RMB 40.84 million[18] Assets and Liabilities - Total assets as of Q3 2024 stood at 2.04 billion yuan, a 5.21% increase from the end of the previous year[3] - Total assets reached 2,035,595,020.59 yuan, a 5.2% increase from 1,934,881,553.02 yuan[13] - Monetary funds grew to 736,841,008.77 yuan, up 33.3% from 552,789,166.67 yuan[12] - Accounts receivable increased to 573,843,961.58 yuan, up 9.8% from 522,446,717.63 yuan[12] - Inventory rose to 37,320,993.03 yuan, a 29.7% increase from 28,782,648.84 yuan[12] - Total current assets reached 1,743,106,265.64 yuan, up 7.6% from 1,620,471,886.98 yuan[12] - Total liabilities decreased to 227,134,222.05 yuan, down 1.9% from 231,560,646.94 yuan[13] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 18,844[8] - Forward Investment (Hong Kong) Limited holds 22.01% of the shares, totaling 87,701,616 shares[8] - Hong Kong Securities Clearing Company Limited holds 8.01% of the shares, totaling 31,911,806 shares[8] - Xiamen Yixiang Investment Partnership holds 5.03% of the shares, totaling 20,026,900 shares[8] - Xiamen Keying Investment Partnership holds 4.98% of the shares, totaling 19,866,146 shares[8] - Lin Zuohua holds 1.69% of the shares, totaling 6,741,471 shares, including 4,670,703 shares through a margin trading account[9] - The total number of restricted shares at the end of the period is 4,897,930, with 62,000 shares released and 900 shares added during the period[10] - The company's restricted shares include 4,327,500 shares held by 386 core management and technical (business) personnel under the 2023 restricted stock incentive plan[10] - Share repurchases in the first three quarters of 2024 increased by 164.74% year-over-year, totaling 136.78 million yuan[6] Operating Costs and Expenses - Operating costs rose to 596,597,050.32 yuan, a 14.1% increase from 522,953,544.65 yuan in the previous year[15] - R&D expenses grew to 164,361,893.33 yuan, up 9.0% from 150,754,888.33 yuan in the previous year[15] Government Subsidies and Other Income - Government subsidies for the first three quarters of 2024 totaled 11.40 million yuan, a 43.38% decrease year-over-year[6] - Fair value change income increased to RMB 6.41 million, up 24.3% YoY from RMB 5.16 million[16]